11-(2-fluoroethyl)estradiol (FETS)
4
relevant articles (0 outcomes,
0 trials/studies)
found for this Bio-Agent
Description:
structure given in first source
Also Known As:
FETS; 11-(2-fluoroethyl)estra-1,3,5(10)-triene-3,17-diol
Bio-Agent Context: Research Results
Experts
Related Diseases
| 1. | Multiple Endocrine Neoplasia Type 1 (MEN I)
|
| 2. | Fibroadenoma
10/01/2007
- " RESULTS: Quantitative measures of stromal cellularity, stromal-epithelial ratio, mitotic rate, stromal overgrowth, and mean nuclear diameter were developed and found to stratify a population of FETs by the current classification system of fibroadenoma, benign, and low-grade or high-grade malignant phyllodes tumor" 10/01/2007
- " DESIGN: Hematoxylin-eosin-stained sections of 41 FETs previously identified as fibroadenoma, benign phyllodes, low-grade malignant phyllodes, or high-grade malignant phyllodes were blinded and studied using a Leica DMRA2 microscope and OpenLab Image Analysis software"
Get all the results and reference details, order at left...
|
| 3. | T-Cell Lymphoma (Lymphoma, T Cell)
|
| 4. | Wounds and Injuries (Trauma)
|
| 5. | Syndrome
|
| 9 Diseases
and
4
more articles analyzed in the Research Interface, order at left...
|
Related Drugs and Biologics